Measuring the total haemoglobin concentration for anaemia in the blood
hemochroma PLUS is a handheld device that can run tests for anaemia. The hemochroma PLUS offers instant access to hemoglobin and calculated hematocrit results, empowering healthcare professionals to make real-time treatment decisions
US FDA 510(K) CLIA waived
Quick test results in 3 seconds
User-friendly graphic interface
Stores 1,000 results onboard
Cleared for patients 6 months or older
Reagent-free microcuvettes
Microcuvette shelf life of up to 2 years, even afterthe canister has been opened
Measurement range 5.0 to 25.6 g/dL
Small 15 ul sample volume
3.25″ Color LCD Display
AFIAS-6
Automated Immunoassay Analyser with the all-in-one cartridge system
AFIAS-6 is a unique integrated (sample-to-answer) system. It features 6 parallel tests of differing parameters, fast turn-around, and high sensitivity, rivalling those of the full-featured systems in commercial labs.
Automated POCT system with All-in-One cartridges
Easy to use with proprietary C-tips (for fingertip blood)
Up to 6 different parallel tests
HSA registered
T2Bacteria® Panel: It’s the first FDA-cleared and CE-marked test panel capable of identifying six common bacterial pathogens.
Time Efficiency: Delivers results in 3 to 5 hours directly from a whole blood sample.
Pathogens Detected: Includes E. faecium, S. aureus, K. pneumoniae, A. baumannii, P. aeruginosa, and E. coli.
Clinical Relevance: These bacteria are prevalent in emergency departments and are often responsible for hospital-acquired infections.
ESKAPE Pathogens: Some detected species are ESKAPE pathogens, known for their virulence and resistance to empiric antimicrobial therapy.
Impact on Patient Care: Quick identification of these pathogens is crucial for timely and targeted treatment, which can significantly improve patient outcomes.
Innovation: The T2Dx Instrument represents a breakthrough in diagnostic technology, enabling direct detection from whole blood samples.
Automation: Fully automated system with walk-away operation, minimising human intervention once the test is set up.
Efficiency: Can run multiple tests simultaneously directly from whole blood, without prior sample preparation.
Capabilities: The T2Dx Instrument provides rapid results, within 3 to 5 hours.
User-Friendly: Simple user interface with a touchscreen display. Step-by-step text and illustrative prompts for easy operation.
Versatility: The instrument can run various tests, including the HSA-registered T2Bacteria and T2Candida Panels
The OSOM Ultra Plus Flu A & B Test is an in vitro rapid qualitative test that detects influenza type A and type B nucleoprotein antigens directly from nasal swab and nasopharyngeal swab specimens obtained from patients with signs and symptoms of respiratory infection.
Meets the Influenza reclassification requirements for rapid antigen tests *Refer to the Package Insert for additional performance claims.
Simple CLIA-waived procedure with pre-measured extraction buffer for swab samples
Accurate, differentiated interpretation of results in 10 minutes to test and treat patients in one office visit
QC Inside®: 2 Additional test sticks for external QC
A rapid test for the detection of Trichomonas vaginalis
The only CLIA-waived rapid test for the detection of Trichomoniasis
95% agreement with culture and wet mount combined
Detects the antigen; does not require live organism
Results in 10 minutes or less
Objective, easy-to-read two-colour results
96% Sensitivity, 95% Specificity
OSOM® BVBLUE® Test
Rapid test for the diagnosis of bacterial vaginosis. Detects elevated vaginal fluid sialidase activity, an enzyme produced by bacterial pathogens associated with bacterial vaginosis, including Gardnerella, Bacteroides, Prevotella and Mobiluncus.
Detects all four major pathogens which cause BV. The test uses a vaginal swab; a speculum may not be required. Storage refrigerated at 2–8 °C.
Certifications: CLIA-waived.
Ordering information: Control kit (sold separately) includes one positive and one negative control.
NEO-BIL PLUS: An advanced version of traditional bilirubinometers.
Purpose: Designed to analyze ‘total bilirubin’ levels in newborns to monitor jaundice progression.
Experience: Over 20 years in the field of physics-chemistry led to this innovation.
Technology: Utilizes advanced technology to eliminate the need for frequent adjustments and standard resetting.
Sample Measurement: Precise measurement of bilirubin and interferentials at the same point in the capillary.
Sample Size: Capable of reading small quantities of serum (10 ul).
Reagents: No reagents are required for operation.
Built-in Printer: Comes with an integrated printer for sequential result printing.
This device represents a significant step forward in neonatal care, providing accurate and efficient bilirubin level monitoring.
Sexually transmitted infections (STIs) primarily spread through unprotected sexual contact. Given their high infection rates and potential co-infections, identifying the specific pathogens responsible is crucial. Additionally, many STIs remain asymptomatic, emphasizing the need for regular testing. Untreated STIs can lead to serious complications, including ectopic pregnancy, infertility, chronic pelvic pain, and neonatal infections.
Allplex™ STI Essential Assay is a multiplex real-time PCR assay that can identify 7 major pathogens (CT, NG, MG, TV, MH, UU, UP) that can cause STI. This assay enables syndromic testing of STIs with its ability to detect causative pathogens accurately.
Also, it can provide even more comprehensive syndromic testing when used with Seegene’s other STI products.
Key Features
High multiplex detection
Detects and identifies 7 major pathogens
(CT, NG, MG, TV, MH, UU, UP) of STI simultaneously in one tube, with a single test
Wide range of specimen
Application of diverse specimens associated with STI
High specificity
Cross-reactivity does not occur with other closely related species
Syndromic test
Combination test available with Seegene’s other STI assays (Allplex™ Candidiasis Assay, Allplex™ Genital ulcer Assay, Allplex™ Bacterial Vaginosis Assay) to comprehensively detect causative pathogens of STI
The Diesse CUBE 30 Touch is an automated analyser for erythrocyte sedimentation rate (ESR) that assesses whole blood directly from EDTA tubes without using up the patient’s sample. It delivers results within 20 minutes and includes an internal mixing function that can process up to 30 samples in one batch.
The Diesse CUBE 30 Touch is equipped with a touchscreen interface, a bar-code reader, and a printer and does not need a dedicated citrate tube.
USER FRIENDLY:
Up to 30 samples simultaneously
Internal bar-code reader
Ease of use
Reduction of turn-around time
Standardisation
Internal mixing of samples by complete inversion of the tubes
